Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days for obtaining the report for the test Acute Lymphoblastic Leukemia (ALL) Panel By PCR is typically 7-10 days. However, this timeframe can vary depending on the laboratory and other factors.

What are the prerequisites for the test Acute Lymphoblastic Leukemia (ALL) Panel By PCR

  • Peripheral blood or bone marrow sample
  • Patient consent for testing
  • Requisition form with patient information
  • Clinical history of the patient
  • Complete blood count (CBC) results
  • Other relevant laboratory test results

What are the measure values for the test Acute Lymphoblastic Leukemia (ALL) Panel By PCR

  • BCR/ABL1: Positive or Negative
  • BCR/ABL1 (p190): Positive or Negative
  • BCR/ABL1 (p210): Positive or Negative
  • BCR/ABL1 (p230): Positive or Negative
  • TCR Gene Rearrangement: Positive or Negative
  • IGH Gene Rearrangement: Positive or Negative
  • TCR Gamma Gene Rearrangement: Positive or Negative
  • TCR Beta Gene Rearrangement: Positive or Negative

What does this test Acute Lymphoblastic Leukemia (ALL) Panel By PCR identify?

The Acute Lymphoblastic Leukemia (ALL) Panel By PCR identifies specific genetic abnormalities associated with Acute Lymphoblastic Leukemia (ALL). This test uses polymerase chain reaction (PCR) to amplify and detect genetic mutations or rearrangements in DNA samples. The results of this test can help diagnose ALL and guide treatment decisions. Some of the genetic abnormalities that may be identified in this panel include translocations involving the MLL gene, BCR-ABL fusion gene, TEL-AML1 fusion gene, and E2A-PBX1 fusion gene.

Why is this test Acute Lymphoblastic Leukemia (ALL) Panel By PCR taken?

The Acute Lymphoblastic Leukemia (ALL) Panel By PCR test is taken to detect and monitor the presence of specific genetic markers associated with ALL, a type of cancer that affects the white blood cells.

This test is typically ordered when a healthcare provider suspects that a patient may have ALL based on symptoms such as unexplained bruising or bleeding, frequent infections, fatigue, and enlarged lymph nodes.

PCR testing is used to identify specific genetic abnormalities, such as chromosomal translocations or gene mutations, that are commonly found in ALL. This information helps to confirm the diagnosis of ALL and determine the best treatment plan for the patient.

No FAQs available.

Customer Google Rating